Intervention Group: ISA-MI for Sudden Infant Death
Phase-Based Progress Estimates
Effectiveness
Safety
Sudden Infant Death+3 More
ISA-MI - BehavioralEligibility
Any Age
All Sexes
What conditions do you have?
Select
Eligibility
Any Age
All Sexes
What conditions do you have?
Select
Study Summary
The study team will evaluate the impact of an Infant Sleep Assessment (ISA) tool with motivational interviewing (MI) communication training on clinician-parent communication during 2-month Well Baby Visits (WBV) and parent reported and observed infant sleep practices. The study team's hypotheses are that 1) clinicians who utilize the ISA with MI training will more effectively communicate safe sleep information to their patients' parents, and 2) these parents will have safer infant sleep practices than parents whose clinicians are in a standard of care control group.
Eligible Conditions
- Sudden Infant Death
- Sudden Unexplained Infant Death
Treatment Effectiveness
Effectiveness Progress
Other trials for Sudden Infant Death
Study Objectives
9 Primary · 6 Secondary · Reporting Duration: Through Study Completion, an average of 2-3 years
2-month Well Baby Visit
Assess quality of infant safe sleep counseling provided by clinicians trained in Motivational Interviewing skills
Assess quality of infant safe sleep counseling provided by clinicians using new EMR-based tool
Changes in quality of infant safe sleep counseling provided by clinicians trained in Motivational Interviewing skills as assessed by listening to recorded 2-month Well Baby Visits for control and intervention groups.
Changes in quality of infant safe sleep counseling provided by clinicians using new EMR-based tool as assessed by listening to recorded 2-month Well Baby Visits for control and intervention groups.
Improvements in quality of infant safe sleep counseling provided by clinicians trained in Motivational Interviewing skills as assessed by listening to recorded 2-month Well Baby Visits for control and intervention groups.
Improvements in quality of infant safe sleep counseling provided by clinicians using new EMR-based tool as assessed by listening to recorded 2-month Well Baby Visits for control and intervention groups.
4 months
Change in parents' satisfaction with care provided by clinical residents
Change in parents' satisfaction with care provided by clinical residents as assessed by the follow-up survey parents in both control and intervention groups will receive at the 4-month Well Baby Visit.
Changes in parents' satisfaction with care provided by clinical residents as assessed by the follow-up survey parents in both control and intervention groups will receive at the 4-month Well Baby Visit.
Review parents' experiences using the ISA tool
Review parents' experiences using the ISA tool as assessed by the Visit Exit Checklist (VEC) survey after the 4-month Well Baby Visit.
Year 3
Analyze ISA's advantages and disadvantages over standard anticipatory guidance
Analyze ISA's advantages and disadvantages over standard anticipatory guidance as assessed by the clinician close-out survey when clinicians graduate or the study ends (whichever happens first).
Analyze clinicians' experiences with the ISA intervention
Interventional procedure
Trial Safety
Safety Progress
Other trials for Sudden Infant Death
Trial Design
1 Treatment Group
Intervention Group: ISA-MI
1 of 1
Experimental Treatment
683 Total Participants · 1 Treatment Group
Primary Treatment: Intervention Group: ISA-MI · No Placebo Group · N/A
Intervention Group: ISA-MI
Behavioral
Experimental Group · 1 Intervention: ISA-MI · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 2-3 years
Who is running the clinical trial?
Johns Hopkins Bloomberg School of Public HealthLead Sponsor
365 Previous Clinical Trials
2,064,256 Total Patients Enrolled
1 Trials studying Sudden Infant Death
214 Patients Enrolled for Sudden Infant Death
National Institute on Minority Health and Health Disparities (NIMHD)NIH
279 Previous Clinical Trials
701,588 Total Patients Enrolled
Marisabel Cordon Villa de Leon, MPHStudy DirectorDivision of General Pediatrics
Barry Solomon, MD, MPHPrincipal InvestigatorDivision of General Pediatrics
Eileen M McDonald, MSPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health
Eligibility Criteria
Age Any Age · All Participants · 2 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:Maryland recognizes teen parents as emancipated minors, so they will be eligible to provide consent and participate.
You are the parents or legal guardians of infants who are under the age of 18 years.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments